![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics
Pfizer Inc announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company...
Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results
Momenta Pharmaceuticals, Inc reported its financial results for the second quarter ended June 30, 2016.For...
Boehringer Ingelheim: Growth in all core businesses
Boehringer Ingelheim reported currency-adjusted growth in all its core businesses in the first half of...
GSK announced the second quarter 2016 and half-yearly financial report for the half-year 2016
GSK delivers further progress against strategy with strong Q2 performance Group sales £6.5 billion, +4%...
Merck Announces Fourth-Quarter 2016 Dividend
Merck known as MSD outside the United States and Canada announced that the Board of...
Novartis Q2 results enhance future growth prospects with eight significant regulatory milestones
Gilenya (USD 811 million, +17% cc) continued to grow double-digit mainly due to volume...
Gilead Sciences to Release Second Quarter 2016 Financial Results on Monday, July 25, 2016
Gilead Sciences, Inc announced that its second quarter 2016 financial results will be released on...
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2016
Johnson & Johnson today announced that its Board of Directors has declared a cash dividend...
Johnson & Johnson Announces Completion of Acquisition of Vogue International LLC
Johnson & Johnson announced that Johnson & Johnson Consumer Inc. has successfully completed the acquisition...
Alexion Pharmaceuticals to Report Second Quarter 2016 Results
Alexion Pharmaceuticals, Inc. announced that the Company will report its financial results for the second...